Grupo 1
Enfermedades Infecciosas
Publicaciones (1225)
-
Aguilera-Correa, JJ; Salinas, B; Gonzalez-Arjona, M; de Pablo, D; Munoz, P; Bouza, E; Acenero, MJF; Esteban, J; Desco, M; Cusso, L.
Positron Emission Tomography-Computed Tomography and Magnetic Resonance Imaging Assessments in a Mouse Model of Implant-Related Bone and Joint Staphylococcus aureus Infection
Microbiology spectrum. 2023; 11(3): Nº de citas: 2 [doi:10.1128/spectrum.04540-22]
-
Cercenado E; Rodríguez-Baño J; Alfonso JL; Calbo E; Escosa L; Fernández-Polo A; García-Rodríguez J; Garnacho J; Gil-Navarro MV; Grau S; Gudiol C; Horcajada JP; Larrosa N; Martínez C; Molina J; Nuvials X; Oliver A; Paño-Pardo JR; Pérez-Rodríguez MT; Ramírez P; Rey-Biel P; Vidal P; Retamar-Gentil P.
Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP.
Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 2023; 41(4): 238-242 [doi:10.1016/j.eimce.2022.05.013]
-
Veintimilla, C; Alvarez-Uria, A; Martin-Rabadan, P; Valerio, M; Machado, M; Padilla, B; Alonso, R; Diez, C; Munoz, P; Marin, M.
Pneumocystis jirovecii Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary Centre
Journal of Fungi. 2023; 9(4): Nº de citas: 9 [doi:10.3390/jof9040414]
-
Pinna, SM; Casasnovas, IS; Olmedo, M; Machado, M; Fernandez, MJ; Devesa-Cordero, C; Galar, A; Alvarez-Uria, A; Fernandez-Aviles, F; Carreno, JG; Martinez-Selles, M; De Rosa, FG; Corcione, S; Bouza, E; Munoz, P; Valerio, M.
Nosocomial Infections in Adult Patients Supported by Extracorporeal Membrane Oxygenation in a Cardiac Intensive Care Unit
Microorganisms. 2023; 11(4): Nº de citas: 10 [doi:10.3390/microorganisms11041079]
-
Cobos, A; Valerio, M; Palomo, M; Adan, I; Catalan, P; Veintimilla, C; Lopez-Andujar, F; Rincon, C; Galar, A; Alonso, R; Machado, M; Gijon, P; Lois, TAE; Latorre, LP; Diez, C; Fanciulli, C; Santiago, EB; Munoz, P.
Demographic, clinical and microbiological characteristics of the first 30 human monkeypox confirmed cases attended in a tertiary hospital in Madrid (Spain), during the May-June 2022 international outbreak
REVISTA ESPANOLA DE QUIMIOTERAPIA. 2023; 36(2): 194-200 Nº de citas: 6 [doi:10.37201/req/112.2022]
-
Bouza, E; Arango, C; Moreno, C; Gracia, D; Martin, M; Perez, V; Lazaro, L; Ferre, F; Salazar, G; Tejerina-Picado, F; Navio, M; Revilla, JG; Palomo, E; Gil-Monte, PR.
Impact of the COVID-19 pandemic on the mental health of the general population and health care workers
REVISTA ESPANOLA DE QUIMIOTERAPIA. 2023; 36(2): 125-143 Nº de citas: 8 [doi:10.37201/req/018.2023]
-
Rinaldi, M; Bonazzetti, C; Gallo, M; Ferraro, G; Freire, M; Terrabuio, DRB; Tandoi, F; Romagnoli, R; De Rosa, FG; Mularoni, A; Ferrarese, A; Burra, P; Halpern, M; Balbi, E; Simkins, J; Abbo, L; Morras, I; Cantero, M; Alagna, L; Bandera, A; Clemente, WT; Valerio, M; Fernandez, A; Munoz, P; Statlender, L; Yahav, D; Camargo, LFA; Girao, ES; Grossi, P; Viale, P; Curti, S; Giannella, M.
Validation of the INCREMENT-SOT-CPE score in a large cohort of liver transplant recipients with carbapenem-resistant Enterobacterales infection
TRANSPLANT INFECTIOUS DISEASE. 2023; 25(2): Nº de citas: 4 [doi:10.1111/tid.14036]
-
Bouza, E; Burillo, A; Munoz, P.
How to manage skin and soft-tissue infections in the emergency department
CURRENT OPINION IN INFECTIOUS DISEASES. 2023; 36(2): 81-88 Nº de citas: 7 [doi:10.1097/QCO.0000000000000906]
-
Martin-Sanchez, FJ; Martinez-Selles, M; Molero García JM; Moreno Guillén S; Rodriguez-Artalejo, F; Ruiz-Galiana, J; Canton, R; De Lucas Ramos P; Garcia-Botella, A; Garcia-Lledo, A; Hernandez-Sampelayo, T; Gomez-Pavon, J; González Del Castillo J; Martin-Delgado, MC; Bouza, E.
Insights for COVID-19 in 2023
REVISTA ESPANOLA DE QUIMIOTERAPIA. 2023; 36(2): 114-124 Nº de citas: 54 [doi:10.37201/req/122.2022]
-
Rodriguez-Temporal, D; Zvezdanova, ME; Benedi, P; Marin, M; Blazquez-Sanchez, M; Ruiz-Serrano, MJ; Munoz, P; Rodriguez-Sanchez, B.
Identification of Nocardia and non-tuberculous Mycobacterium species by MALDI-TOF MS using the VITEK MS coupled to IVD and RUO databases
Microbial Biotechnology. 2023; 16(4): 778-783 Nº de citas: 6 [doi:10.1111/1751-7915.14146]
-
Martinez-Lirola, M; Herranz, M; Serrano, SB; Rodriguez-Grande, C; Inarra, ED; Garrido-Cardenas, JA; Ruiz, AMC; Bermudez, MP; del Rio, MC; Galan, VG; Armenteros, JL; Martinez, JMV; Vallejo-Godoy, S; Garcia, ABE; Fernandez, MTC; Munoz, P; Lago, LP; de Viedma, DG.
A One Health approach revealed the long-term role of Mycobacterium caprae as the hidden cause of human tuberculosis in a region of Spain, 2003 to 2022
Eurosurveillance. 2023; 28(12): Nº de citas: 5 [doi:10.2807/1560-7917.ES.2023.28.12.2200852]
-
de Egea, GL; Gonzalez-Diaz, A; Guedon, G; Lao, JL; Berbel, D; Casabella, A; Marimon, JM; Cercenado, E; Fernandez-Delgado, L; Chiapello, H; Lacroix, T; Dominguez, MA; Leblond-Bourget, N; Ardanuy, C.
A New Integrative and Mobilizable Element Is a Major Contributor to Tetracycline Resistance in Streptococcus dysgalactiae subsp. equisimilis
Antibiotics-Basel. 2023; 12(3): Nº de citas: 4 [doi:10.3390/antibiotics12030579]
-
Fernandez-Ruiz, M; Bodro, M; Martin, IG; Rodriguez-Alvarez, R; Ruiz-Ruigomez, M; Sabe, N; Lopez-Vinau, T; Valerio, M; Illaro, A; Fortun, J; Salto-Alejandre, S; Cordero, E; Farinas, MD; Munoz, P; Vidal, E; Carratala, J; Goikoetxea, J; Ramos-Martinez, A; Moreno, A; Aguado, JM.
Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice
TRANSPLANTATION. 2023; 107(3): 762-773 Nº de citas: 6 [doi:10.1097/TP.0000000000004312]
-
Fernandez-Alonso, V; Rodriguez-Fernandez, S; Secadas-Rincon, L; Perez-Gomez, M; Moro-Tejedor, MN; Salcedo, M.
Resilience After COVID-19: A Descriptive, Cross-Sectional Study
CLINICAL NURSING RESEARCH. 2023; 32(3): 618-628 Nº de citas: 6 [doi:10.1177/10547738231154326]
-
Serrano-Lobo, J; Gomez, A; Reigadas, E; Munoz, P; Escribano, P; Guinea, J.
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato
MYCOSES. 2023; 66(3): 196-201 Nº de citas: 1 [doi:10.1111/myc.13541]
-
Busca, A; Salmanton-Garcia, J; Marchesi, F; Farina, F; Seval, GC; Van Doesum, J; De Jonge, N; Bahr, NC; Maertens, J; Meletiadis, J; Fracchiolla, NS; Weinbergerova, B; Verga, L; Racil, Z; Jimenez, M; Glenthoj, A; Blennow, O; Tanase, AD; Schonlein, M; Prezioso, L; Khanna, N; Duarte, RF; Zak, P; Nucci, M; Machado, M; Kulasekararaj, A; Espigado, I; De Kort, E; Susana, JMRS; Marchetti, M; Magliano, G; Falces-Romero, I; Ilhan, O; Ammatuna, E; Zompi, S; Tsirigotis, P; Antoniadou, A; Zambrotta, GPM; Nordlander, A; Karlsson, LK; Hanakova, M; Dragonetti, G; Cabirta, A; Venemyr, CB; Grafe, S; Van Praet, J; Tragiannidis, A; Petzer, V; Lopez-Garcia, A; Itri, F; Groh, A; Gavriilaki, E; Dargenio, M; Rahimli, L; Cornely, OA; Pagano, L.
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
Frontiers in Immunology. 2023; 14: Nº de citas: 33 [doi:10.3389/fimmu.2023.1125030]
-
Varona, JF; Landete, P; Paredes, R; Vates, R; Torralba, M; Guisado-Vasco, P; Porras, L; Munoz, P; Gijon, P; Ancochea, J; Saiz, E; Meira, F; Jimeno, JM; Lopez-Martin, JA; Estrada, V.
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis
Frontiers in Cellular and Infection Microbiology. 2023; 13: Nº de citas: 4 [doi:10.3389/fcimb.2023.1097809]
-
de la Villa, S; Herrero, S; Munoz, P; Rodriguez, C; Valerio, M; Reigadas, E; Alvarez-Uria, A; Alcala, L; Marin, M; Olmedo, M; Kestler, M; Chamorro, E; Bouza, E.
Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
Open Forum Infectious Diseases. 2023; 10(2): Nº de citas: 7 [doi:10.1093/ofid/ofad028]